A novel monoclonal antibody developed by US researchers has demonstrated strong protection against malaria in an early clinical trial, offering a new preventive approach against the deadly disease.
The antibody, named MAM01, was tested by scientists at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD). The trial showed that MAM01 provided dose-dependent full protection against malaria parasites with minimal side effects.
“This new monoclonal antibody could transform how we prevent malaria in young children and pregnant women,” said Kirsten E. Lyke, Professor of Medicine and lead author. “Unlike vaccines requiring multiple doses or boosters, a single injection of a long-acting antibody could provide immediate, months-long protection.”
Malaria remains one of the leading causes of child mortality in sub-Saharan Africa, claiming over 600,000 lives annually. Despite advances in vaccines and treatment, prevention remains a major global health challenge.
The study, published in The Lancet Infectious Diseases, revealed that MAM01 targets a highly conserved region of the parasite’s surface protein, effectively blocking infection before the parasite reaches the bloodstream.
Co-author Matthew B. Laurens, Professor of Pediatrics, noted that “these results suggest this monoclonal antibody can provide reliable protection against malaria, which continues to disproportionately affect children in low- and middle-income countries.”
With further trials planned, MAM01 could represent a major step toward equitable, long-term malaria prevention.
Get Latest News Live on MTIMES along with Breaking News and Top Headlines, Political News and around The World.
You May Like
Trending Searches Today |
Odisha SSB Lecturers Protest for UGC Pay Parity and Service Recognition
Donald Trump’s 100% Tariffs on Indian Pharma Exports to US Spark Market Concerns
BSNL 4G Services at ₹1: Apply Now Free 30-Day Offer Diwali Bonanza Plan
Indian Army and BSF Personnel Celebrated Diwali Along Border Areas
Thamma Box Office: Ayushmann Khurrana’s Biggest Opener Set to Break Records
PM Modi Highlights Role of AI in Unlocking India’s Ancient Manuscripts
- Add Videos as Watch Faces: Make your watch uniquely yours by setting a 3-5 second video from your gallery as your watch …
- Heart Rate Variability (HRV) Tracking: Gain more profound insights into your heart rate fluctuations with HRV tracking. …
- 1.51” (3.83 cm) AMOLED Display with BT Calling: Enjoy vivid and sharp visuals on the 3.83 cm (1.51”) AMOLED display. Wit…
